Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Armand

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Bulletin Du Cancer|November 26, 1999
[Rapamycin and CCI-779]J Alexandre, E Raymond, J P Armand
Hematology/Oncology Clinics of North America|August 1, 1991
Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implicationsE Cvitkovic, M Bachouchi, J P Armand
Cancer Research|September 1, 1984
Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II)J P Macquet, S Cros, J P Armand
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trialsJ P Armand, L Seymour, T R Evans
Pathologie-Biologie|June 7, 2006
[Targeting angiogenesis in oncology]J Fayette, J-C Soria, J-P Armand
Bulletin Du Cancer|January 1, 1990
[Fluorine-19 nuclear magnetic resonance spectroscopy: a privileged tool for the study of the metabolism and pharmacokinetics of fluoropyrimidines]M C Malet-Martino, R Martino, J P Armand
Annals of the New York Academy of Sciences|December 13, 1996
CPT-11. The European experienceJ P Armand, C Terret, C Couteau, et al.
Cancer Treatment Reports|April 1, 1983
Phase II clinical evaluation of 4'-epi-doxorubicinP Hurteloup, P Cappelaere, J P Armand, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Hormonal steroid receptors in intracranial tumours and their relevance in hormone therapyP Courriere, M Tremoulet, N Eche, et al.
Pediatrie|June 1, 1984
[Dyssegmental dwarfism. A new case]J Maisonneuve, J P Armand, J J Louis, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Bulletin Du Cancer|November 26, 1999
[Rapamycin and CCI-779]J Alexandre, E Raymond, J P Armand
Hematology/Oncology Clinics of North America|August 1, 1991
Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implicationsE Cvitkovic, M Bachouchi, J P Armand
Cancer Research|September 1, 1984
Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II)J P Macquet, S Cros, J P Armand
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trialsJ P Armand, L Seymour, T R Evans
Pathologie-Biologie|June 7, 2006
[Targeting angiogenesis in oncology]J Fayette, J-C Soria, J-P Armand
Bulletin Du Cancer|January 1, 1990
[Fluorine-19 nuclear magnetic resonance spectroscopy: a privileged tool for the study of the metabolism and pharmacokinetics of fluoropyrimidines]M C Malet-Martino, R Martino, J P Armand
Annals of the New York Academy of Sciences|December 13, 1996
CPT-11. The European experienceJ P Armand, C Terret, C Couteau, et al.
Cancer Treatment Reports|April 1, 1983
Phase II clinical evaluation of 4'-epi-doxorubicinP Hurteloup, P Cappelaere, J P Armand, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Hormonal steroid receptors in intracranial tumours and their relevance in hormone therapyP Courriere, M Tremoulet, N Eche, et al.
Pediatrie|June 1, 1984
[Dyssegmental dwarfism. A new case]J Maisonneuve, J P Armand, J J Louis, et al.
Pageof 15